45
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Yolk Sac Tumor of the Ovary in Mosaic 46XX Turner Syndrome

ORCID Icon, , &
Pages 629-635 | Received 13 Feb 2024, Accepted 09 Apr 2024, Published online: 16 Apr 2024

References

  • Zhong Q, Layman LC. Genetic considerations in the patient with Turner syndrome--45,X with or without mosaicism. Fertil Steril. 2012;98(4):775–779. doi:10.1016/j.fertnstert.2012.08.021
  • Taubel DA, Rebar RW. Puberty. In: Berek JS, editor. Berek & Novak’s Gynecology. Philadelphia: Wolters Kluwer; 2020.
  • Obata NH, Nakashima N, Kawai M, Kikkawa F, Mamba S, Tomoda Y. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype. Gynecol Oncol. 1995;58(1):124–128. doi:10.1006/gyno.1995.1195
  • Zhao S, Kato N, Endoh Y, Jin Z, Ajioka Y, Motoyama T. Ovarian gonadoblastoma with mixed germ cell tumor in a woman with 46, XX karyotype and successful pregnancies. Pathol Int. 2000;50(4):332–335. doi:10.1046/j.1440-1827.2000.01041.x
  • Erhan Y, Toprak AS, Ozdemir N, Tiras B. Gonadoblastoma and fertility. J Clin Pathol. 1992;45(9):828–829. doi:10.1136/jcp.45.9.828
  • Erdemoglu E, Ozen S. Ovarian gonodoblastoma with yolk sac tumor in a young 46, XX female: case report. Eur J Gynaecol Oncol. 2007;28(6):516–518.
  • Raafey MA, Abdulwaasey M, Fatima SS, Uddin Z, Tariq MU. Bilateral gonadoblastoma with dysgerminoma in a phenotypically normal female with 46XX karyotype: report of a rare case and literature review. Cureus. 2020;12(7):e8990. doi:10.7759/cureus.8990
  • Gorosito M, Pancera B, Sarancone S, Nocito AL. Gonadoblastoma: an unusual ovarian tumor. Ann Diagn Pathol. 2010;14(4):247–250. doi:10.1016/j.anndiagpath.2010.03.006
  • Young RH, Clement PB, Scully RE. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament: atlas of tumor pathology; 1999.
  • Berek JS, English DP, Longacre TA, Friedlander M. Ovarian, fallopian tube, and peritoneal cancer. In: Berek JS, editor. Berek & Novaks Gynecology. 16th ed. Philadelphia: Wolters Wilkins; 2020.
  • Saani I, Raj N, Sood R, et al. Clinical challenges in the management of malignant ovarian germ cell tumours. Int J Environ Res Public Health. 2023;20(12):6089. doi:10.3390/ijerph20126089
  • Ito K, Kawamata Y, Osada H, Ijichi M, Takano H, Sekiya S. Pure yolk sac tumor of the ovary with mosaic 45X/46X + mar Turner’s syndrome with a Y-chromosomal fragment. Arch Gynecol Obstet. 1998;262(1–2):87–90. doi:10.1007/s004040050233
  • Bremer GL, Land JA, Tiebosch A, van der Putten HW. Five different histological subtypes of germ cell malignancies in an XY female. Gynecol Oncol. 1993;50(2):247–248. doi:10.1006/gyno.1993.1201
  • Boussios S, Moschetta M, Tatsi K, Tsiouris AK, Pavlidis N. A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: diagnostic and therapeutic perspectives. J Adv Res. 2018;12:1–9. doi:10.1016/j.jare.2018.02.006
  • Lau YF, Li Y, Kido T. Gonadoblastoma locus and the TSPY gene on the human Y chromosome. Birth Defects Res C Embryo Today. 2009;87(1):114–122. doi:10.1002/bdrc.20144
  • Scully RE. Gonadoblastoma. A review of 74 cases. Cancer. 1970;25(6):1340–1356. doi:10.1002/1097-0142(197006)25:6<1340::AID-CNCR2820250612>3.0.CO;2-N
  • Chandrapattan P, Jena A, Patnayak R, Mangaraj S, Naik S, Panda S. Gonadoblastoma with dysgerminoma presenting as virilizing disorder in a young child with 46, XX karyotype: a case report and review of the literature. Case Rep Endocrinol. 2022;2022:5666957. doi:10.1155/2022/5666957
  • Canto P, Kofman-Alfaro S, Jiménez AL, et al. Gonadoblastoma in Turner syndrome patients with nonmosaic 45,X karyotype and Y chromosome sequences. Cancer Genet Cytogenet. 2004;150(1):70–72. doi:10.1016/j.cancergencyto.2003.08.011
  • Gravholt CH, Andersen NH, Conway GS, et al. Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. Eur J Endocrinol. 2017;177:3.
  • Mittal S, Weaver J, Aghababian A, et al. Deferring gonadectomy in patients with turner syndrome with a genetic Y component is not a safe practice. J Pediatr Urol. 2023;19(3):294.e1–e5. doi:10.1016/j.jpurol.2022.12.012
  • Gravholt CH, Fedder J, Naeraa RW, Müller J. Occurrence of gonadoblastoma in females with turner syndrome and Y chromosome material: a population study*. J Clin Endocrinol Metab. 2000;85(9):3199–3202.
  • Sybert VP. Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome. J Med Genet. 2002;39(3):217–220. doi:10.1136/jmg.39.3.217
  • Kao CS, Idrees MT, Young RH, Ulbright TM. “Dissecting gonadoblastoma” of scully: a morphologic variant that often mimics germinoma. Am J Surg Pathol. 2016;40(10):1417–1423. doi:10.1097/PAS.0000000000000704
  • Kang H, Kim TJ, Kim WY, et al. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor. Gynecol Oncol. 2008;111(1):106–110. doi:10.1016/j.ygyno.2008.05.033
  • Satoh T, Aoki Y, Kasamatsu T, et al. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour. Eur J Cancer. 2015;51(3):340–351. doi:10.1016/j.ejca.2014.12.004
  • Billmire D, Vinocur C, Rescorla F, et al. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J Pediatr Surg. 2004;39(3):424–429. doi:10.1016/j.jpedsurg.2003.11.027
  • NCCN. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. NCCN Clinical Practice Guidelines in Oncology; 2024.
  • Chan JK, Tewari KS, Waller S, et al. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008;98(2):111–116. doi:10.1002/jso.21079
  • Maidarti M, Garinasih PD, Anggraeni TD. Conservative surgical staging as a means to preserve fertility in patients with dysgerminoma: a case report. Ann Med Surg. 2023;85(3):427–430. doi:10.1097/MS9.0000000000000146